CEMIP2 and polycystic kidney disease: More recently, it has been demonstrated that the ratio between the two urinary exosomal proteins polycystin-1 (PC1) and transmembrane protein 2 (TMEM2) could be used to distinguish individuals with polycystic kidney disease-1 (PKD1) mutations from healthy controls [26].